Literature DB >> 23444007

Changing interactions between physician trainees and the pharmaceutical industry: a national survey.

Kirsten E Austad1, Jerry Avorn, Jessica M Franklin, Mary K Kowal, Eric G Campbell, Aaron S Kesselheim.   

Abstract

BACKGROUND: Increasingly, medical school policies limit pharmaceutical representatives' access to students and gifts from drugmakers, but little is known about how these policies affect student attitudes toward industry.
OBJECTIVE: To assess interactions between trainees and the pharmaceutical industry, and to determine whether learning environment characteristics influence students' practices and attitudes. DESIGN, PARTICIPANTS: We conducted a cross-sectional survey with a nationally-representative sample of first- and fourth-year medical students and third-year residents, stratified by medical school, including ≥ 14 randomly selected trainees at each level per school. MAIN MEASURES: We measured frequency of industry interactions and attitudes regarding how such interactions affect medical training and the profession. Chi-squared tests assessed bivariate linear trend, and hierarchical logistic regression models were fitted to assess associations between trainees' attitudes and their schools' National Institutes of Health (NIH) funding levels and American Medical Student Association (AMSA) PharmFree Scorecard grades reflecting industry-related conflict of interest policies. KEY
RESULTS: Among 1,610 student (49.3 % response rate) and 739 resident (43.1 %) respondents, industry-sponsored gifts were common, rising from 33.0 % (first-year students) to 56.8 % (fourth-year students) and 54 % (residents) (p < 0.001). These gifts included meals outside the hospital (reported by 5 % first-year students, 13.4 % fourth-year students, 27.5 % residents (p < 0.001)) and free drug samples (reported by 7.4 % first-year students, 14.1 % fourth-year students, 14.3 % residents (p < 0.001)). The perception that industry interactions lead to bias was prevalent, but the belief that physicians receive valuable education through these interactions increased (64.1 % to 67.5 % to 79.8 %, p < 0.001). Students in schools receiving more NIH funding reported industry gifts less often (OR = 0.51, 95 % CI: 0.38-0.68, p < 0.001), but the strength of institutional conflict of interest policies was not associated with this variable.
CONCLUSIONS: Despite recent policy changes, a substantial number of trainees continue to receive gifts from pharmaceutical representatives. We found no relation between these outcomes and a school's policies concerning interactions with industry.

Entities:  

Mesh:

Year:  2013        PMID: 23444007      PMCID: PMC3710396          DOI: 10.1007/s11606-013-2361-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  28 in total

1.  Physicians and the pharmaceutical industry: is a gift ever just a gift?

Authors:  A Wazana
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

2.  Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study.

Authors:  Audiey C Kao; Clarence Braddock; Maria Clay; Donna Elliott; Scott K Epstein; William Filstead; Tim Hotze; Win May; Jennifer Reenan
Journal:  Acad Med       Date:  2011-11       Impact factor: 6.893

3.  The social mission of medical education: ranking the schools.

Authors:  Fitzhugh Mullan; Candice Chen; Stephen Petterson; Gretchen Kolsky; Michael Spagnola
Journal:  Ann Intern Med       Date:  2010-06-15       Impact factor: 25.391

4.  Funding for medical education: maintaining a healthy separation from industry.

Authors:  Jerry Avorn; Niteesh K Choudhry
Journal:  Circulation       Date:  2010-05-25       Impact factor: 29.690

5.  Response rates and nonresponse errors in surveys.

Authors:  Timothy P Johnson; Joseph S Wislar
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

6.  Future directions in industry funding of continuing medical education.

Authors:  Robert Steinbrook
Journal:  Arch Intern Med       Date:  2011-02-14

7.  Closing the door on pharma? A national survey of family medicine residencies regarding industry interactions.

Authors:  Adriane Fugh-Berman; Steven R Brown; Rachel Trippett; Alicia M Bell; Paige Clark; Anthony Fleg; Jay Siwek
Journal:  Acad Med       Date:  2011-05       Impact factor: 6.893

8.  Conflict of interest disclosure in early education of medical students.

Authors:  Kirsten E Austad; Aaron S Kesselheim
Journal:  JAMA       Date:  2011-09-07       Impact factor: 56.272

9.  Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints.

Authors:  Aaron S Kesselheim; Michelle M Mello; David M Studdert
Journal:  PLoS Med       Date:  2011-04-05       Impact factor: 11.069

Review 10.  Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review.

Authors:  Kirsten E Austad; Jerry Avorn; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2011-05-24       Impact factor: 11.069

View more
  21 in total

1.  Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.

Authors:  James S Yeh; Kirsten E Austad; Jessica M Franklin; Susan Chimonas; Eric G Campbell; Jerry Avorn; Aaron S Kesselheim
Journal:  J Grad Med Educ       Date:  2015-12

2.  Physician trainees' interactions with the pharmaceutical industry.

Authors:  Kirsten E Austad; Jerry Avorn; Jessica M Franklin; Aaron S Kesselheim
Journal:  J Gen Intern Med       Date:  2013-10       Impact factor: 5.128

3.  Physician trainees' interactions with the pharmaceutical industry.

Authors:  Reshma Ramachandran; Marcia Hams; Jean Silver-Isenstadt
Journal:  J Gen Intern Med       Date:  2013-10       Impact factor: 5.128

4.  Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals.

Authors:  Klaus Lieb; Cora Koch
Journal:  Dtsch Arztebl Int       Date:  2013-09-02       Impact factor: 5.594

5.  Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data.

Authors:  Andre M Samuel; Matthew L Webb; Adam M Lukasiewicz; Daniel D Bohl; Bryce A Basques; Glenn S Russo; Vinay K Rathi; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2015-06-19       Impact factor: 4.176

6.  Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.

Authors:  Amie C O'Donoghue; Vanessa Boudewyns; Kathryn J Aikin; Emily Geisen; Kevin R Betts; Brian G Southwell
Journal:  J Health Commun       Date:  2015-07-15

7.  Scientism in Medical Education and the Improvement of Medical Care: Opioids, Competencies, and Social Accountability.

Authors:  Lynette Reid
Journal:  Health Care Anal       Date:  2018-06

8.  An Elective Course for Student Pharmacists on Pharmaceutical Industry Practice.

Authors:  Bobby Jacob; Samuel K Peasah
Journal:  Am J Pharm Educ       Date:  2019-10       Impact factor: 2.047

9.  Antipsychotic prescribing: do conflict of interest policies make a difference?

Authors:  Timothy S Anderson; Haiden A Huskamp; Andrew J Epstein; Colleen L Barry; Aiju Men; Ernst R Berndt; Marcela Horvitz-Lennon; Sharon-Lise Normand; Julie M Donohue
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

10.  Conflicts of interest in medical school: missing policies and high need for student information at most German universities.

Authors:  Klaus Lieb; Cora Koch
Journal:  GMS Z Med Ausbild       Date:  2014-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.